MannKind Corp (MNKD)
6.90
+0.02
(+0.29%)
USD |
NASDAQ |
Nov 21, 16:00
6.95
+0.05
(+0.72%)
After-Hours: 20:00
MannKind Gross Profit Margin (Quarterly): 74.28% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 74.28% |
June 30, 2024 | 71.85% |
March 31, 2024 | 71.93% |
December 31, 2023 | 69.10% |
September 30, 2023 | 72.19% |
June 30, 2023 | 70.71% |
March 31, 2023 | 60.09% |
December 31, 2022 | 55.28% |
September 30, 2022 | 46.81% |
June 30, 2022 | 31.64% |
March 31, 2022 | 8.29% |
December 31, 2021 | 8.64% |
September 30, 2021 | 55.49% |
June 30, 2021 | 57.36% |
March 31, 2021 | 56.35% |
December 31, 2020 | 65.93% |
September 30, 2020 | 66.31% |
Date | Value |
---|---|
June 30, 2020 | 62.55% |
March 31, 2020 | 53.64% |
December 31, 2019 | 56.10% |
September 30, 2019 | 38.78% |
June 30, 2019 | 56.90% |
March 31, 2019 | 68.15% |
December 31, 2018 | 62.18% |
September 30, 2018 | -18.66% |
June 30, 2018 | -30.88% |
March 31, 2018 | -15.67% |
December 31, 2017 | -10.77% |
September 30, 2017 | -123.9% |
June 30, 2017 | -135.1% |
March 31, 2017 | 15.32% |
December 31, 2016 | -16.40% |
September 30, 2016 | 83.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
8.29%
Minimum
Mar 2022
74.28%
Maximum
Sep 2024
55.73%
Average
58.73%
Median
Gross Profit Margin (Quarterly) Benchmarks
Mirum Pharmaceuticals Inc | 76.98% |
NovaBay Pharmaceuticals Inc | 65.26% |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | 4.94% |
Return on Invested Capital | 110.1% |
Profit Margin (Quarterly) | 16.48% |
Operating Margin (Quarterly) | 21.71% |
Return on Net Operating Assets | 16.10% |